Previous close | 21.30 |
Open | 21.30 |
Bid | 22.10 |
Ask | 23.40 |
Strike | 85.00 |
Expiry date | 2025-01-17 |
Day's range | 21.30 - 21.30 |
Contract range | N/A |
Volume | |
Open interest | 971 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cencora's (COR) second-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
The U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer. The U.S. Food and Drug Administration in 2023 recommended against the use of some China-made syringes as it investigated reports of leaks, breakages and other quality problems with such products and last month expanded the guidance. Cardinal did not immediately respond to a Reuters request for comment.